Barington Companies Management LLC Makes New $5.56 Million Investment in Chemed Corporation $CHE

Barington Companies Management LLC bought a new position in Chemed Corporation (NYSE:CHE) in the fourth quarter, HoldingsChannel reports. The fund bought 13,000 shares of the company’s stock, valued at approximately $5,562,000. Chemed makes up approximately 3.7% of Barington Companies Management LLC’s portfolio, making the stock its 8th biggest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CHE. Los Angeles Capital Management LLC purchased a new stake in Chemed in the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC increased its stake in shares of Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after purchasing an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. acquired a new position in shares of Chemed during the 4th quarter worth $27,000. Global Retirement Partners LLC increased its stake in shares of Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares during the last quarter. Finally, Rothschild Investment LLC increased its stake in shares of Chemed by 800.0% during the 4th quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock worth $46,000 after purchasing an additional 96 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on CHE shares. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada increased their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Oppenheimer dropped their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Chemed presently has an average rating of “Hold” and an average price target of $501.50.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the transaction, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 3.33% of the stock is currently owned by company insiders.

Chemed Stock Performance

NYSE CHE opened at $419.07 on Friday. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The firm has a market capitalization of $5.56 billion, a price-to-earnings ratio of 22.84, a P/E/G ratio of 1.58 and a beta of 0.54. The company’s fifty day moving average is $415.27 and its two-hundred day moving average is $424.51. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $562.77.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period last year, the business posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.